Patents by Inventor Patrick R. Hagner

Patrick R. Hagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240228667
    Abstract: Provided herein are methods of treating multiple myeloma, comprising administering to a subject with multiple myeloma an inhibitor of Nuclear Receptor Binding SET Domain Protein 2 (NSD2). Also provided are methods of use wherein the multiple myeloma has previously been determined to have a 4:14 chromosome translocation (t(4;14)).
    Type: Application
    Filed: February 25, 2022
    Publication date: July 11, 2024
    Applicant: Celgene Corporation
    Inventors: Nicholas Stong, Patrick R. Hagner, William Edward Pierceall, Anjan Thakurta, Jennifer Erin Flynt, Maria Ortiz-Estevez
  • Publication number: 20240132623
    Abstract: Provided herein are methods of treating multiple myeloma, comprising administering to a subject with multiple myeloma an inhibitor of Nuclear Receptor Binding SET Domain Protein 2 (NSD2). Also provided are methods of use wherein the multiple myeloma has previously been determined to have a 4:14 chromosome translocation (t(4;14)).
    Type: Application
    Filed: February 25, 2022
    Publication date: April 25, 2024
    Applicant: Celgene Corporation
    Inventors: Nicholas Stong, Patrick R. Hagner, William Edward Pierceall, Anjan Thakurta, Jennifer Erin Flynt, Maria Ortiz-Estevez
  • Patent number: 9956226
    Abstract: Methods for inhibiting translation, treating a cellular proliferative disorder, and inhibiting proliferation of cells using the compounds disclosed herein are provided.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: May 1, 2018
    Assignee: President and Fellows of Harvard College
    Inventors: Gerhard Wagner, Ricard A. Rodriguez-Mias, Patrick R. Hagner
  • Publication number: 20150374707
    Abstract: Methods for inhibiting translation, treating a cellular proliferative disorder, and inhibiting proliferation of cells using the compounds disclosed herein are provided.
    Type: Application
    Filed: February 11, 2014
    Publication date: December 31, 2015
    Inventors: Gerhard Wagner, Ricard A. Rodriguez-Mias, Patrick R. Hagner